Involvement of heparanase in tumor progression and normal differentiation

Pathophysiology of Haemostasis and Thrombosis

Volumn 33, Issue SUPPL. 1, 2003, Pages 59-61

  Vlodavsky, I ^a,b   Zcharia, E ^b   Goldshmidt, O ^a,b   Eshel, R ^c   Katz, B Z ^c   Minucci, S ^d   Kovalchuk, O ^b   Penco, S ^e   Pisano, C ^e   Naggi, A ^f   Casu, B ^f  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^e Sigma Tau SpA   (Italy)

^f Istituto di Ricerche Chimiche e Biochimiche G Ronzoni   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARANASE; HISTONE; RETINOIC ACID; VITAMIN D;

ANGIOGENESIS; CELL DIFFERENTIATION; CELL MATURATION; CONFERENCE PAPER; DOWN REGULATION; ENZYME ACTIVITY; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; TISSUE REGENERATION; TUMOR CELL; TUMOR GROWTH;

EID: 10744230039     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073296     Document Type: Conference Paper

References (10)

1. Vlodavsky I, Friedmann Y: Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest 2001;108:341-347.
2. Parish CR, Freeman C, Hulett MD: Heparanase: A key enzyme involved in cell invasion. Biochim Biophys Acta 2001;1471:M99-M108.
3. Goldshmidt O, Zcharia E, Cohen M, Aingorn H, Nadav L, Cohen I, Katz B-Z, Geiger B, Vlodavsky I: Heparanase mediates cell adhesion independent of its enzymatic activity. Faseb J 2003;17:1015-1025.
4. Gohji K, Hirano H, Okamoto M, Kitazawa S, Toyoshima M, Dong J, Katsuoka Y, Nakajima M: Expression of three extracellular matrix degradative enzymes in bladder cancer. Int J Cancer 2001;95:295-301.
5. Elkin M, Ilan N, Ishai-Michaeli R, Friedmann Y, Papo O, Pecker I, Vlodavsky I: Heparanase as mediator of angiogenesis: Mode of action. Faseb J 2001;15:1661-1663.
6. Parish CR, Freeman C, Brown KJ, Francis DJ, Cowden WB: Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity. Cancer Res 1999;59:3433-3441.
7. Casu B, Naggi A, Torri G: Chemical derivatization as a strategy to study structure-activity relationships of glycosaminoglycans. Semin Thromb Hemost 2002;28:335-342.
8. Casu B, Guerrini M, Naggi A, Perez M, Torri G, Ribatti D, Carminati P, Giannini G, Penco S, Pisano C, Belleri M, Rusnati M, Presta M: Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitors. Biochemistry 2002;41:10519-10528.
9. Vlodavsky I, Eldor A, Haimovitz-Friedman A, Matzner Y, Ishai-Michaeli R, Lider O, Naparstek Y, Cohen IR, Fuks Z: Expression of heparanase by platelets and circulating cells of the immune system: Possible involvement in diapedesis and extravasation. Invasion Metastasis 1992;12:112-127.
10. Bitan M, Polliack A, Zecchina G, Nagler A, Friedmann Y, Nadav L, Deutsch V, Pecker I, Eldor A, Vlodavsky I, Katz B-Z: Heparanase expression in human leukemias is restricted to AML. Exp Hematol 2002;30:34-41.